Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and Without RAS Mutations: Results of NLMT Arm J

G. Middleton,P. Fletcher,J. Savage, M. Mehmi,A. Greystoke, A. Dangoor,J. Cave,C. Escriu,P. Shaw,N. Steele,P. Jain,S. Popat,M. Forster,J. Spicer,N. Coupe,S. Danson,D. Gilligan,D. Muthukumar,G. Price,Y. Summers,E. Toy,L. Billingham

Journal of Thoracic Oncology（2023）

Cited 0|Views34
Key words
ceralasertib,durvalumab,RAS
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined